ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$100.55
*  
0.18
0.18%
Get ALNY Alerts
*Delayed - data as of Nov. 28, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Many Sharp Minds Are Invested Long In Tekmira
11/21/2014 1:11:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 12:21:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - SeekingAlpha


Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14)
11/18/2014 6:40:00 AM - Seeking Alpha


Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog
11/17/2014 6:40:00 PM - Zacks.com


Alnylam Pharma Announces Positive Initial Phase 2 Data With Revusiran
11/14/2014 6:12:00 AM - RTT News


Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
11/12/2014 5:40:00 PM - Zacks.com


Isis Pharmaceuticals Inc. Strikes Out on Its Own
11/7/2014 2:30:27 PM - Motley Fool


Alnylam Pharmaceuticals Staying Ridiculously Busy
11/7/2014 11:25:00 AM - Seeking Alpha


Alnylam's Q3 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog
11/6/2014 12:40:00 PM - Zacks.com


Investing in Socially Responsible Companies: Alnylam Pharmaceuticals, Inc.
11/6/2014 10:22:02 AM - Motley Fool


Alnylam Pharmaceuticals, Inc. Has This Ratio Right
11/5/2014 8:33:39 PM - Motley Fool


Alnylam Pharma Loss Narrower Than Street
11/5/2014 5:46:00 PM - RTT News


Will Perrigo (PRGO) Disappoint This Earnings Season? - Analyst Blog
11/4/2014 4:45:00 PM - Zacks.com


Will Humana (HUM) Miss on Earnings Estimates this Season? - Analyst Blog
11/4/2014 3:50:00 PM - Zacks.com


Will Actavis (ACT) Beat Earnings Estimates on Forest Deal? - Analyst Blog
11/3/2014 5:20:00 PM - Zacks.com


Is Hospira (HSP) Poised to Beat Q3 Earnings Estimates? - Analyst Blog
11/3/2014 5:00:00 PM - Zacks.com


Will Becton, Dickinson (BDX) Beat Q4 Earnings Estimates? - Analyst Blog
10/31/2014 3:53:00 PM - Zacks.com


Will IoT Market Focus Help Atmel (ATML) Beat Q3 Earnings? - Analyst Blog
10/27/2014 6:20:00 PM - Zacks.com


5 Best Biotech Stocks to Buy Now
10/21/2014 9:33:02 AM - InvestorPlace Media


Moving Average Crossover Alert: Alnylam Pharmaceuticals (ALNY) - Tale of the Tape
10/16/2014 7:24:20 AM - Zacks.com


Alnylam Reveals Positive Data from its Pipeline Candidates - Analyst Blog
10/15/2014 3:30:00 PM - Zacks.com


Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
10/14/2014 3:45:00 PM - Zacks.com